ANXA2
ATC code L01
Abemaciclib
Acalabrutinib (data page)
Adagrasib
Adipotide
Afatinib
Aflibercept
Alectinib
Alemtuzumab
Alexion Pharmaceuticals
Alpelisib
American Society of Health-System Pharmacists
Amivantamab
Anaplastic lymphoma kinase
Anastrozole
Anatomical Therapeutic Chemical Classification System
Andexanet alfa
Anifrolumab
Antineoplastic
Asciminib
Asfotase alfa
AstraZeneca
Astra AB
Astra Zeneca
Atenolol
Atezolizumab
Atezolizumab/hyaluronidase
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
BRAF (gene)
Baricitinib
Bcr-abl fusion protein
Belantamab mafodotin
Benralizumab
Bermekimab
Bevacizumab
Bicalutamide
Binimetinib
Blinatumomab
Bosutinib
Brentuximab vedotin
Brigatinib
Brompheniramine
Bruton's tyrosine kinase
Budesonide
Budesonide/formoterol
Budesonide/glycopyrronium bromide/formoterol
C-Met
CAS Registry Number
CD117
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabozantinib
Cambridge Antibody Technology
Cancer immunotherapy
Candesartan
Capmatinib
Catumaxomab
Cediranib
Cemiplimab
Ceritinib
Cetuximab
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chronic lymphocytic leukemia
Cobimetinib
Copanlisib
Cosibelimab
Crizotinib
Dabrafenib
Dacomitinib
DailyMed
Dalpiciclib
Dapagliflozin
Daratumumab
Dasatinib
Denileukin diftitox
Dinutuximab beta
Disufenton sodium
Doi (identifier)
Dostarlimab
DrugBank
Drug nomenclature
Drugs.com
Durvalumab
Duvelisib
ECHA InfoCard
EML4
Eculizumab
Edrecolomab
Elotuzumab
Elranatamab
Encorafenib
Enfortumab vedotin
Entrectinib
EpCAM
Epcoritamab
Epidermal growth factor receptor
ErbB
Erdafitinib
Erlotinib
Esomeprazole
European Medicines Agency
Everolimus
Exenatide
Exotoxin
Fedratinib
Fibroblast growth factor receptor
Filgotinib
Food and Drug Administration
Fruquintinib
Fulvestrant
Fusion protein
Futibatinib
Gefitinib
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Glycopyrronium bromide/formoterol
Goserelin
HER2/neu
Hdl (identifier)
Health Canada
Hedgehog signaling pathway
ISSN (identifier)
IUPAC nomenclature of chemistry
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idelalisib
Imatinib
Inavolisib
Indication (medicine)
Infigratinib
Inotuzumab ozogamicin
Interleukin 2
International Chemical Identifier
International nonproprietary name
Ipilimumab
Isatuximab
Isosorbide mononitrate
JSmol
Janus kinase
KEGG
KRAS
Lapatinib
Larotrectinib
Lazertinib
Lenvatinib
Lestaurtinib
Leukemia
Live attenuated influenza vaccine
Loncastuximab tesirine
Lorlatinib
Louis Schweitzer (CEO)
Low platelets
Low red blood cells
Low white blood cells
Lymphatic system
Lymphoma
MEN1
MTOR inhibitor
Mantle cell lymphoma
Masitinib
MedImmune
MedlinePlus
Metoprolol
Midostaurin
Mirvetuximab soravtansine
Mitogen-activated protein kinase kinase
Mobocertinib
Mogamulizumab
Molar mass
Momelotinib
Monoclonal antibody therapy
Mosunetuzumab
Motavizumab
Moxetumomab pasudotox
Myeloid
Naxitamab
Necitumumab
Neratinib
Nilotinib
Nintedanib
Nivolumab
Non-Hodgkin lymphoma
Non-receptor tyrosine kinase
Obinutuzumab
Odronextamab
Ofatumumab
Olaparib
Olaratumab
Olmutinib
Omeprazole
Oportuzumab monatox
Oral administration
Orelabrutinib
Orphan drug
Osimertinib
Oxford–AstraZeneca COVID-19 vaccine
PMC (identifier)
PMID (identifier)
Pacritinib
Palbociclib
Palivizumab
Panitumumab
Parsaclisib
Pazopanib
Pembrolizumab
Pemigatinib
Pertuzumab
Pexidartinib
Pi3K inhibitor
Pirtobrutinib
Platelet-derived growth factor receptor
Polatuzumab vedotin
Ponatinib
Pralsetinib
Pregnancy category
Prescription drug
Proapoptotic
Prohibitin
Prolgolimab
Propofol
Protein Data Bank
PubChem
Quetiapine
Quizartinib
RET proto-oncogene
RTK class III
Radotinib
Ramucirumab
Ravulizumab
Receptor tyrosine kinase
Regorafenib
Regulation of therapeutic goods
Repotrectinib
Retifanlimab
Revumenib
Ribociclib
Ridaforolimus
Ripretinib
Rituximab
Rociletinib
Roflumilast
Rosuvastatin
Route of administration
Roxadustat
Ruxolitinib
Sabatolimab
Sacituzumab govitecan
Salbutamol/budesonide
Savolitinib
Saxagliptin
Sebelipase alfa
Selpercatinib
Selumetinib
Semaxanib
Serplulimab
Simplified molecular-input line-entry system
Sirolimus
Small lymphocytic lymphoma
Sodium zirconium cyclosilicate
Sonidegib
Sorafenib
Sotorasib
Src (gene)
Standard for the Uniform Scheduling of Medicines and Poisons
Sugemalimab
Sunitinib
Tafasitamab
Talquetamab
Tamoxifen
Targeted cancer therapy
Tarlatamab
Tebentafusp
Teclistamab
Temsirolimus
Tepotinib
Therapeutic Goods Administration
Ticagrelor
Tislelizumab
Tisotumab vedotin
Tivozanib
Tixagevimab/cilgavimab
Toceranib
Tom McKillop
Toripalimab
Tositumomab
Trametinib
Trastuzumab
Trastuzumab/hyaluronidase
Trastuzumab deruxtecan
Trastuzumab emtansine
Tremelimumab
Trilaciclib
Tucatinib
Tyrosine kinase inhibitor
Unique Ingredient Identifier
United States Adopted Name
VEGF receptors
Vandetanib
Vascular endothelial growth factor
Vascular endothelial growth factor A
Vemurafenib
Venetoclax
Vismodegib
Waldenström's macroglobulinaemia
Ximelagatran
Zafirlukast
Zanidatamab
Zanubrutinib
Zeneca
Zenocutuzumab
Zolbetuximab
Zolmitriptan